NASDAQ · Biotechnology

IDYA (IDYA) Stock

$40.17 +0.55% NASDAQ: IDYA Healthcare

Valuation

MetricValue
Price$40.17
Market Cap$3.82B
P/E Ratio-22.12
P/B Ratio2.43
P/S Ratio11.42
EPS (TTM)$-1.28
52-Week High$42.58
52-Week Low$20.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-11.14%
ROA-10.28%
ROCE-15.54%
Gross Margin-72.60%
Operating Margin-72.60%
Net Margin-62.17%
Debt/Equity0.03
Current Ratio11.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$28.0M$51.0M$23.0M$7.0M$219.0M
Operating Profit$-50.0M$-63.0M$-134.0M$-327.0M$-159.0M
Net Profit$-50.0M$-59.0M$-113.0M$-274.0M$-114.0M
EPS$-1.41$-1.42$-1.96$-3.36$-1.28
Op Margin-179.9%-122.7%-574.9%-4671.1%-72.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$381.0M$388.0M$649.0M$1.1B$1.1B
Total Liabilities$80.0M$39.0M$28.0M$65.0M$86.0M
Cash$92.0M$69.0M$157.0M$84.0M$113.0M
Borrowings$5.0M$3.0M$3.0M$19.0M$28.0M

Latest News

Ideaya Biosciences Insider Sold Shares Worth $382,131, According to a Recent SEC Filing MT Newswires · Jul 9, 2026 RBC Capital Adjusts IDEAYA Biosciences Price Target to $48 From $53, Maintains Outperform Rating MT Newswires · Jul 7, 2026 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire · Jun 26, 2026 IDEAYA Biosciences Elects CEO Yujiro Hata as Chairman MT Newswires · Jun 17, 2026 IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors PR Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-56.0M$-87.0M$-115.0M$-248.0M$-71.0M
Investing Cash Flow$-72.0M$-37.0M$-161.0M$-506.0M$68.0M
Financing Cash Flow$2.0M$2.0M$11.0M$14.0M$0
Net Cash Flow$20.0M$-23.0M$89.0M$-73.0M$28.0M
Free Cash Flow$-58.0M$-91.0M$-118.0M$-251.0M$-73.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-3.42%
Quick Ratio10.74
Interest Coverage—
Return 1Y60.89%
Return 3Y40.98%
Return 5Y82.24%

Ownership

Insiders Held2.22%
Institutions Held101.90%
Institutions Float Held104.22%
Institutional HolderSharesReport Date
FMR, LLC13,172,1032026-03-31
Blackrock Inc.8,442,1332026-03-31
Janus Henderson Group PLC7,265,2532026-03-31
Capital Research Global Investors5,163,5432026-03-31
Baker Bros. Advisors, LP3,946,5152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADPT $24.66 +1.31% -69.84 $3.95B 0.00%
BEAM $29.29 +0.93% -35.36 $3.01B 0.00%
CDTXCidara Therapeutics, Inc. $221.38 +0.00% -25.99 $5.61B 0.00%
COGT $34.57 -0.32% -34.70 $5.91B 0.00%
FOLDAmicus Therapeutics Inc $14.49 +0.00% -161.00 $4.55B 0.00%

About IDYA

IDYA stock trades at $40.17 with a market capitalization of $3.82B. The stock is valued at a price-to-earnings (P/E) ratio of -22.12, price-to-book of 2.43, price-to-sales of 11.42. Over the past 52 weeks the stock has ranged between $20.50 and $42.58, and currently trades 5.7% below its 52-week high.

On profitability, IDYA generates a return on equity (ROE) of -11.14%, return on capital employed of -15.54%, an operating margin of -72.60%, a net profit margin of -62.17%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides